Get the Stockscreener App
0.0999
1.03%
0.0024
Profusa Inc stock is traded at $0.0999, with a volume of 3.30M.
It is up +1.03% in the last 24 hours and up +37.19% over the past month.
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
See More
Previous Close:
$0.0975
Open:
$0.104
24h Volume:
3.30M
Relative Volume:
0.12
Market Cap:
$8.63M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.58%
1M Performance:
+37.19%
6M Performance:
-85.52%
1Y Performance:
+0.00%
1-Day Range:
$0.0961
$0.104
1-Week Range:
$0.0934
$0.121
52-Week Range:
$0.0651
$2.22
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.0999 | 8.43M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
107.08 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.22 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.58 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.31 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.78 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Profusa Inc Stock (PFSA) Latest News
Contrasting Profusa (NASDAQ:PFSA) & Longevity Health (NASDAQ:XAGE) - Defense World
Profusa restructures senior secured convertible notes - MSN
Profusa launches tissue oxygen monitoring system for research market By Investing.com - Investing.com Nigeria
Profusa Stock Spikes As Lumee System Targets Research Market - Benzinga
Profusa Launches Lumee, Paving Way For First Commercial Revenue; Stock Jumps - Nasdaq
Profusa launches tissue oxygen monitoring system for research market - Investing.com
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First ... - Bluefield Daily Telegraph
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue - GlobeNewswire
Drug trials get new oxygen sensor as Profusa enters $47.9B CRO market - Stock Titan
NorthView Acquisition Corp Announces Filing a Registration Statement on Form S-4 in Connection with a Proposed Business Combination with Profusa, Inc. - Intellectia AI
Profusa, Inc.Common Stock (NQ: PFSA - FinancialContent
Profusa Adds Leading Greek Vascular Surgeon to Customer Base - manilatimes.net
Contact | Statesman-ExaminerProfusa, Inc.Common Stock (Nasdaq:PFSA) Stock Quote - FinancialContent
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Profusa (NASDAQ: PFSA) outlines reverse split plan to address Nasdaq listing rules - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Profusa expands European footprint with French distributor partnership By Investing.com - Investing.com Nigeria
Profusa expands European footprint with French distributor partnership - Investing.com India
Profusa Bolsters European Commercial Network with New French Distributor, MedSell - The Manila Times
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring - ts2.tech
Manufacturing Stocks To Add to Your Watchlist – December 30th - Defense World
Nio, Profusa, Nike, FTAI Aviation And Under Armour: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Profusa (PFSA) Stock Analysis Report | Financials & Insights - Benzinga
Profusa Stock Soars—To 12 Cents—On Debt Restructuring - Sahm
Profusa (PFSA) Stock: Announces Key Changes to Senior Secured Convertible Notes for Stronger Financial Health - parameter.io
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Nasdaq Trading Activity: Profusa Leads High-Volume Movers on December 30, 2025News and Statistics - IndexBox
Profusa amends securities purchase agreement to allow for $5 million note sale - Investing.com Nigeria
Here’s Why Profusa Stock (PFSA) Rocketed Today - TipRanks
US Stocks Lower; Home Price Growth Eases in October - Sahm
Profusa Restructures Senior Secured Convertible Notes; Shares Jump Pre-Bell - marketscreener.com
Profusa restructures convertible note to reduce dilution, increase flexibility - Investing.com
Profusa amends securities purchase agreement to allow for $5 million note sale By Investing.com - Investing.com South Africa
Profusa restructures convertible note to reduce dilution, increase flexibility By Investing.com - Investing.com South Africa
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 - The Manila Times
Profusa Signs Amendment No. 3 to Securities Purchase Agreement With Ascent Partners Fund - TradingView — Track All Markets
[8-K] Profusa, Inc. Reports Material Event | PFSA SEC FilingForm 8-K - Stock Titan
Profusa amends securities purchase agreement to expand financing - MSN
PFSA SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Profusa amends equity deal and convertible note terms - MSN
[424B3] Profusa, Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
Profusa amends securities agreements with Ascent Partners Fund By Investing.com - Investing.com Nigeria
Profusa Amends Equity Deal and Convertible Note Terms - TipRanks
Profusa amends securities agreements with Ascent Partners Fund - Investing.com
Profusa Updates Multiple Financing Agreements With Ascent Partners Fund - TradingView — Track All Markets
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Profusa (NASDAQ: NVACW) details reverse split plan and Nasdaq deficiency risks - Stock Titan
Profusa (NASDAQ:PFSA) versus ReShape Lifesciences (OTCMKTS:RSLSD) Financial Contrast - Defense World
Profusa Inc Stock (PFSA) Financials Data
There is no financial data for Profusa Inc (PFSA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.90%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):